Solicitation, total small business set-aside
Phase I - Serological Assays for the detection and characterization of influenza viruses
75D30125R73211_Phase_I
Centers for Disease Control and Prevention, CDC Office of Acquisition Services. In-Vitro Diagnostic Substance Manufacturing.
Response deadline
November 21, 2024 at 2:00 PM EST
Closed 710 days ago. Posted November 14, 2024. Scheduled to archive April 28, 2025.
Get the next one like this from Centers for Disease Control and Prevention by email, the day it is posted.Find my opportunities
This one closed in 2024
13 like it are open now in in-vitro diagnostic substance manufacturing
- NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes tomorrowNov 2 - HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325413Anywhere in the US36C26227Q0046Closes tomorrowNov 2 - DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325413Anywhere in the US36C77027Q0015Closes in 2 daysNov 3
Description
As published on SAM.gov.
The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
November 14, 2024
Solicitation, originally presolicitation
Due November 21, 2024 at 2:00 PM EST. SAM.gov, notice 9b7ce42c9dbe49d7b0d808b6f8712ffd
Points of contact
- Jennifer Gartzkejgartzke@cdc.gov4044980020